CHLOROQUINE PHOSPHATE Drug Patent Profile
✉ Email this page to a colleague
When do Chloroquine Phosphate patents expire, and what generic alternatives are available?
Chloroquine Phosphate is a drug marketed by Hikma Pharms, Impax Labs, Ipca Labs Ltd, Md Pharm, Natco Pharma Ltd, Purepac Pharm, Suven Pharms, Teva, and Watson Labs. and is included in thirteen NDAs.
The generic ingredient in CHLOROQUINE PHOSPHATE is chloroquine phosphate. There is one drug master file entry for this compound. Five suppliers are listed for this compound. Additional details are available on the chloroquine phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Chloroquine Phosphate
A generic version of CHLOROQUINE PHOSPHATE was approved as chloroquine phosphate by IMPAX LABS on August 29th, 2003.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CHLOROQUINE PHOSPHATE?
- What are the global sales for CHLOROQUINE PHOSPHATE?
- What is Average Wholesale Price for CHLOROQUINE PHOSPHATE?
Summary for CHLOROQUINE PHOSPHATE
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 13 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 109 |
| Clinical Trials: | 49 |
| Patent Applications: | 1,488 |
| DailyMed Link: | CHLOROQUINE PHOSPHATE at DailyMed |
Recent Clinical Trials for CHLOROQUINE PHOSPHATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Translational Genomics Research Institute | Phase 1 |
| HonorHealth Research Institute | Phase 1 |
| Agenus Inc. | Phase 1 |
Pharmacology for CHLOROQUINE PHOSPHATE
| Drug Class | Antimalarial |
Anatomical Therapeutic Chemical (ATC) Classes for CHLOROQUINE PHOSPHATE
US Patents and Regulatory Information for CHLOROQUINE PHOSPHATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma Pharms | CHLOROQUINE PHOSPHATE | chloroquine phosphate | TABLET;ORAL | 083082-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Md Pharm | CHLOROQUINE PHOSPHATE | chloroquine phosphate | TABLET;ORAL | 087228-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Impax Labs | CHLOROQUINE PHOSPHATE | chloroquine phosphate | TABLET;ORAL | 040516-001 | Aug 29, 2003 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Teva | CHLOROQUINE PHOSPHATE | chloroquine phosphate | TABLET;ORAL | 087504-001 | Jan 13, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Natco Pharma Ltd | CHLOROQUINE PHOSPHATE | chloroquine phosphate | TABLET;ORAL | 091621-001 | Jan 21, 2011 | AA | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Watson Labs | CHLOROQUINE PHOSPHATE | chloroquine phosphate | TABLET;ORAL | 088030-001 | Dec 21, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
